MAPT and Alzheimer disease: Stimulation of microglial TLR4 results in NLRP3-dependent inflammasome activation; the resulting IL-1β production has been found to exacerbate neuronal and cognitive dysfunction in rodent AD models, at least in part by amplifying tau phosphorylation [230,231,232,233,234,235,236].